
NewAmsterdam Pharma Grants Stock Options to New Hires Under 2024 Inducement Plan

I'm PortAI, I can summarize articles.
NewAmsterdam Pharma Company N.V. has granted stock options to two new non-executive hires under its 2024 Inducement Plan. The options cover 40,000 shares at an exercise price of $39.61, vesting over four years. This announcement was made via GlobeNewswire and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

